文献速递临床免疫质量管理与危急值

生物素补充对尿液hCG生物素-链霉亲和素免疫分析的影响

Impact of Biotin Supplementation on Human Chorionic Gonadotropin Immunoassays Utilizing Biotin-Streptavidin Binding Methods in Urine.
PubMed 文献 · Clin Chem · 2023-01-01

结果发现补充生物素后尿生物素较基线升高500倍,使用生物素依赖免疫分析时,hCG+生物素组仅19%尿样hCG阳性,而hCG+安慰剂组为71%,且尿hCG与生物素水平呈负相关(Spearman r=-0.46,P<0.0001)。结论提示生物素可严重抑制尿hCG检测值,此类方法不推荐用于高生物素尿样。

要点

  • 补充生物素(20 mg/天)可使尿生物素较基线升高500倍,达血清水平的29倍。
  • 生物素依赖免疫分析中,hCG+生物素组尿hCG阳性率仅19%,远低于安慰剂组的71%。
  • 尿hCG与生物素水平呈负相关(Spearman r=-0.46,P<0.0001),提示生物素干扰。

核心结论

  • 生物素补充可严重抑制采用生物素-链霉亲和素结合方法的尿液hCG免疫分析检测值。
  • 此类生物素依赖免疫分析不推荐用于含高浓度生物素的尿液样本。

研究设计与样本

  • 研究期间收集尿和血清样本,分析hCG和生物素浓度。

主要发现

  • hCG+生物素组尿生物素水平较基线升高500倍,较相应血清生物素水平高29倍。
  • 使用生物素依赖免疫分析时,hCG+安慰剂组71%尿样hCG≥5 mIU/mL,hCG+生物素组仅19%。
  • 两组血清生物素依赖免疫分析hCG值均升高,使用非生物素依赖免疫分析时尿hCG亦升高。
  • hCG+生物素组尿hCG与生物素水平呈负相关(Spearman r=-0.46,P<0.0001,生物素依赖免疫分析)。

关键数值与推荐

  • 尿hCG阳性判定阈值为hCG≥5 mIU/mL。
  • 生物素补充剂量为20 mg/天,持续2周。
  • hCG+生物素组尿生物素较基线升高500倍,较血清高29倍。
  • 生物素依赖免疫分析中,hCG+生物素组尿hCG阳性率19%,hCG+安慰剂组71%。
  • 尿hCG与生物素负相关:Spearman r=-0.46,P<0.0001。

临床怎么用

  • 对使用生物素-链霉亲和素免疫分析平台检测尿hCG时,需考虑高浓度生物素导致的假阴性风险。
  • 尿样中生物素浓度高时,生物素依赖免疫分析结果不可靠,应选用非生物素依赖方法或考虑其他检测策略。

局限性

  • 研究仅涉及特定hCG给药方案和生物素剂量(20 mg/天),其他剂量或人群的干扰程度未明确。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human chorionic gonadotropin (hCG) detection is indicative of pregnancy and can be indicative of some forms of cancerous tumors. The hCG drug itself, however, is a performance enhancing substance used by male athletes to increase testosterone production. Antidoping testing for hCG is conducted in urine, often on immunoanalyzer platforms, many of which utilize biotin-streptavidin dependent immunoassays in which the presence of biotin in samples is a known confounding factor. While biotin interference in serum has been well-studied, the extent of biotin interference in urine has not. METHODS: Ten active male individuals underwent a 2-week hCG administration protocol concurrent with supplementation with biotin (20 mg/day) or placebo. Urine and serum samples were collected throughout the study and analyzed for hCG and biotin concentrations. RESULTS: Urinary biotin levels in the hCG + biotin group increased 500-fold over baseline and 29-fold over corresponding serum biotin levels after biotin supplementation. When using a biotin-dependent immunoassay, the hCG + placebo group produced hCG-positive results (hCG ≥ 5 mIU/mL) in 71% of urine samples, while the hCG + biotin group produced positive results in only 19% of samples. Both groups had elevated hCG values in serum measurements by a biotin-dependent immunoassay and in urine when using a biotin-independent immunoassay. Urinary hCG measurements and biotin levels from the hCG + biotin group showed a negative correlation (Spearman r = -0.46, P < 0.0001) when measured using a biotin-dependent immunoassay. CONCLUSIONS: Biotin supplementation can severely suppress urinary hCG values in assays utilizing biotin-streptavidin binding methods and therefore these types of assays are not recommended for use in urine samples containing high levels of biotin. Clinicaltrials.gov Registration Number: NCT05450900.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Goodrum JM, Nair VS, Moore C, et al. Impact of Biotin Supplementation on Human Chorionic Gonadotropin Immunoassays Utilizing Biotin-Streptavidin Binding Methods in Urine. Clin Chem. 2023. PMID: 37253044. doi:10.1093/clinchem/hvad060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。